Skip to main content
Signal8

Gold Alexander M

SEC insider (Form 3/4/5 filer). CIK 0002026429. Director at Mineralys Therapeutics, Inc. (MLYS). 11 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in RADNOR, PA.

Companies Gold Alexander M has filed insider reports for

  • Mineralys Therapeutics, Inc. (MLYS): Director
Gold Alexander M profile photo

Gold Alexander M

CIK: 0002026429

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (45.5%)

Position reduction

Option Exercises (M)4 (36.4%)

Derivative conversions

Awards (A)2 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Mineralys Therapeutics, Inc. logo
MLYS

Mineralys Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Feb 19, 2026
    Award
    Direct
    6.2K shares-
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 13, 2025
    Sale
    Direct
    12.7K shares at avg. $46.50$593K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 13, 2025
    Exercise
    Direct
    2.7K shares at avg. $10.20$28K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 13, 2025
    Exercise
    Direct
    10K shares at avg. $12.69$127K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 12, 2025
    Exercise
    Direct
    6.9K shares at avg. $10.20$71K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 12, 2025
    Sale
    Direct
    5K shares at avg. $46.50$233K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 12, 2025
    Sale
    Direct
    1.9K shares at avg. $47.28$91K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 11, 2025
    Exercise
    Direct
    15K shares at avg. $10.20$153K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 11, 2025
    Sale
    Direct
    10K shares at avg. $42.43$424K
  • Mineralys Therapeutics, Inc. logo
    MLYS

    Mineralys Therapeutics, Inc.

    Nov 11, 2025
    Sale
    Direct
    5K shares at avg. $47.08$235K

1-10 of 11